Edison Liu

Edison T. Liu is an American chemist who is the former president and CEO of The Jackson Laboratory, and the former director of its NCI-designated Cancer Center (2012-2021).

From 1987 to 1996, Liu was a faculty member at the University of North Carolina at Chapel Hill, where he was the director of the Lineberger Comprehensive Cancer Center's Specialized Program of Research Excellence in Breast Cancer; the director of the Laboratory of Molecular Epidemiology at UNC School of Public Health; chief of Medical Genetics; and the chair of the Correlative Science Committee of the national cooperative clinical trials group, CALGB.

In his spare time, Liu[4] pursues jazz piano and composition, and writes for the lay public on science, medicine and society.

Chemistry, Psychology 2021–present Professor, President Emeritus, and Honorary Fellow, The Jackson Laboratory 2011-2021 President and CEO, The Jackson Laboratory 2001-2011 Executive Director, Genome Institute of Singapore 2007–2011 Chairman, Governing Board Health Sciences Authority of Singapore 1996-2001 Director, Division of Clinical Sciences, National Cancer Institute, Bethesda, MD 1995-1996 Chief, Division of Medical Genetics, UNC School of Medicine 1995-1996 Professor, UNC Departments of Medicine, Epidemiology, Biochemistry and Biophysics.

1993-1995 Associate Professor, Departments of Medicine and Epidemiology and Biochemistry, University of North Carolina at Chapel Hill 1992-1996 Director, Specialized Program of Research Excellence in Breast Cancer (NIH-designated) 1987-1993 Assistant Professor in Medicine and Oncology, UNC School of Medicine 2018 Honorary Degree recipient, University of Southern Maine 2016 Honorary Degree recipient, Colby College[5] 2016 Elected Fellow, American Association for the Advancement of Science 2014 Chen Award for Distinguished Academic Achievement in Human Genetic and Genomic Research (from Human Genome Organization) 2010 Fellow, The Hastings Center 2008 Associate (Foreign) Member European Molecular Biology Organization (EMBO) 2007-2013 President, the Human Genome Organization (HUGO) 2007 Doctor of Medical Science honoris causa, awarded by Queen's University Belfast 2005 National Healthcare Group (NHG), Singapore, Distinguished Contributor Award 2003 Public Service Medal (National Day, 2003), for work in controlling SARS in Singapore (given by the Office of the President, Republic of Singapore) 2000 Rosenthal Award, AACR: for the discovery that HER-2 status determines response to adjuvant chemotherapy with doxorubicin 1999 Elected-Board of Directors, American Association for Cancer Research 1996 Brinker International Award for Breast Cancer Research - Basic Research Award 1995 American Society of Clinical Investigation (Membership) 1991-1996 Leukemia and Lymphoma Society Scholar 1985-1988 Clinical Investigator Award, National Cancer Institute, K08-CA01036-02, Preceptor: Dr. J. Michael Bishop.